New Deal
Hannah Deresiewicz
Managing Director at Stern IR
PR Consultant
Deal Bio
Expertise (7)
Key Relationships
Announcement Date
Deal Value
Forty Seven
Gilead Sciences
£3,821m
48 dealmakers
MYOKARDIA
Bristol Myers Squibb Company
£10,012m
53 dealmakers
Prime Medicine
T. Rowe Price Group
£227m
17 dealmakers
EYSUVIS
Alcon
£48m
6 dealmakers
Tyme Technologies
Syros Pharmaceuticals
£49m
13 dealmakers
Newamsterdam Pharma Holding
Frazier Lifesciences Acquisition Corpoartion
£270m
55 dealmakers
Ifm Due
Novartis
£650m
7 dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.